News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dolan Matthew Vincent
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| Dolan Matthew Vincent (SVP Corporate Strategy-Develop) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,303 shares
@ $115, valued at
$264.8k
|
|
| 03/14/2023 |
4
| Dolan Matthew Vincent (SVP Corporate Strategy-Develop) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed/sold 1,370 shares
@ $111.399, valued at
$152.6k
Disposed/sold 1,650 shares
@ $111.399, valued at
$183.8k
Disposed/sold 2,397 shares
@ $111.399, valued at
$267k
Disposed/sold 787 shares
@ $111.399, valued at
$87.7k
Sold 6,229 shares
@ $106.27, valued at
$662k
|
|
| 03/10/2023 |
4
| Dolan Matthew Vincent (SVP Corporate Strategy-Develop) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 21,769 shares
@ $0.001, valued at
$21.8 |
|
| 03/06/2023 |
4
| Dolan Matthew Vincent (SVP Corporate Strategy-Develop) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 226 shares
@ $114.4, valued at
$25.9k
|
|
| 09/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|